Librium (Chlordiazepoxide Hydrochloride)

Chlordiazepoxide binds to the benzodiazepine site on the GABA‑A receptor, enhancing the natural inhibitory action of GABA. This increases chloride ion flow into neurons, producing hyperpolarisation that reduces neuronal firing, resulting in anxiolytic, sedative, muscle‑relaxant, and anticonvulsant effects.

The appropriate dose of Librium is determined by a qualified prescriber based on the individual’s medical condition, age, response to therapy, and other medications. Dosage regimens are individualized and should follow the prescribing information provided by the healthcare professional.

Librium is classified as Pregnancy Category D, indicating evidence of risk to the fetus. It should be used in pregnancy only if the potential benefit justifies the risk. Breastfeeding is not recommended because the drug passes into milk and may affect the infant. Consultation with a healthcare provider is essential.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Librium. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The team then replies with pricing, availability, shipping details and any required import documentation.

Librium (chlordiazepoxide) is an older, long‑acting benzodiazepine, whereas alternatives like diazepam or lorazepam may have different onset times and half‑lives. Chlordiazepoxide’s prolonged duration can be advantageous for managing alcohol withdrawal, but may increase the risk of accumulation and sedation in some patients compared with shorter‑acting agents.

Store Librium tablets at ambient temperature, preferably below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture, heat and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Librium is supplied as oral tablets that are taken by mouth with or without food, as directed by a prescriber. Swallow the tablet whole; do not crush, chew, or split unless specifically instructed by a healthcare professional.

The most serious risks include respiratory depression, especially when combined with other CNS depressants, severe hypotension, paradoxical reactions such as aggression or hallucinations, and the potential for dependence, tolerance and withdrawal seizures if the medication is stopped abruptly.

Librium should be avoided in patients with known hypersensitivity to chlordiazepoxide or other benzodiazepines, those with severe respiratory insufficiency, acute narrow‑angle glaucoma, severe hepatic impairment, or a history of substance‑use disorder unless closely monitored. Pregnant women should only use it when clearly indicated by a physician.